Total Payments
$17,557
2023 Payments
$6,665
Companies
3
Transactions
26
Medicare Patients
8,125
Medicare Billing
$844,775
Payment Breakdown by Category
Other$12,255 (69.8%)
Consulting$3,750 (21.4%)
Travel$1,171 (6.7%)
Food & Beverage$374.35 (2.1%)
Education$6.10 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,255 | 16 | 69.8% |
| Consulting Fee | $3,750 | 1 | 21.4% |
| Travel and Lodging | $1,171 | 4 | 6.7% |
| Food and Beverage | $374.35 | 4 | 2.1% |
| Education | $6.10 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $17,518 | 24 | $0 (2023) |
| Lantheus Medical Imaging, Inc. | $19.30 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $19.25 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $6,665 | 7 | PFIZER INC. ($6,665) |
| 2022 | $1,954 | 4 | PFIZER INC. ($1,935) |
| 2021 | $3,231 | 6 | PFIZER INC. ($3,231) |
| 2020 | $430.00 | 1 | PFIZER INC. ($430.00) |
| 2019 | $5,276 | 8 | PFIZER INC. ($5,257) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| 11/02/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| 08/24/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| 06/23/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| 04/28/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| 02/24/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| 01/13/2023 | PFIZER INC. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/03/2022 | PFIZER INC. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2022 | PFIZER INC. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2022 | PFIZER INC. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/02/2022 | Philips Electronics North America Corporation | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: Medical Device | ||||||
| 11/12/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 10/25/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 08/20/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 07/23/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 04/07/2021 | PFIZER INC. | VYNDAMAX (Drug) | Education | In-kind items and services | $6.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/25/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 12/18/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $430.00 | General |
| 12/19/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $130.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2019 | PFIZER INC. | VYNDAQEL (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $381.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $347.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $312.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $255.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/14/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $80.66 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,020 | 2,631 | $643,275 | $193,167 |
| 2022 | 12 | 1,986 | 2,679 | $624,130 | $197,658 |
| 2021 | 12 | 1,944 | 2,588 | $715,140 | $225,106 |
| 2020 | 15 | 2,175 | 2,853 | $758,775 | $228,844 |
Total Patients
8,125
Total Services
10,751
Medicare Billing
$844,775
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 499 | 683 | $140,015 | $63,096 | 45.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 102 | 102 | $148,920 | $38,496 | 25.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 196 | 198 | $170,280 | $31,185 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $25,200 | $10,462 | 41.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 641 | 874 | $48,070 | $9,710 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 153 | $21,420 | $9,552 | 44.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 64 | 244 | $13,420 | $9,331 | 69.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 103 | 103 | $10,100 | $7,781 | 77.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 79 | 79 | $19,750 | $3,864 | 19.6% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Office | 2023 | 12 | 12 | $9,480 | $3,753 | 39.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 40 | 40 | $28,400 | $2,286 | 8.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,160 | $1,771 | 42.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 19 | $2,660 | $1,276 | 48.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 28 | 28 | $1,400 | $604.52 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 572 | 801 | $164,205 | $74,944 | 45.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 111 | 111 | $162,060 | $44,256 | 27.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 177 | 179 | $153,940 | $28,704 | 18.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 79 | 316 | $17,380 | $13,556 | 78.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 625 | 849 | $46,695 | $9,449 | 20.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 113 | 113 | $11,350 | $8,805 | 77.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $16,380 | $5,873 | 35.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 86 | 86 | $21,500 | $4,478 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 64 | $8,960 | $4,137 | 46.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 23 | 23 | $16,330 | $1,338 | 8.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 45 | 45 | $2,250 | $983.45 | 43.7% |
About Dr. Scott Jerome, D.O
Dr. Scott Jerome, D.O is a Cardiovascular Disease healthcare provider based in Reisterstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942203245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Jerome, D.O has received a total of $17,557 in payments from pharmaceutical and medical device companies, with $6,665 received in 2023. These payments were reported across 26 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,255).
As a Medicare-enrolled provider, Jerome has provided services to 8,125 Medicare beneficiaries, totaling 10,751 services with total Medicare billing of $844,775. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Reisterstown, MD
- Active Since 05/31/2005
- Last Updated 03/06/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1942203245
Products in Payments
- VYNDAQEL (Drug) $5,257
- ELIQUIS (Drug) $2,580
- Definity (Drug) $19.30
- (5050) Ext Holter (Device) $19.25
- VYNDAMAX (Drug) $6.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.